See All Slides - tctmd.com

Slides

Presentation TCT 2017

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Samir R. Kapadia, Ioanna Kosmidou

November 01, 2017

Presentation TCT 2017

My Worst Complication That Was Preventable

Presenter: Jeffrey W. Moses, R. Michael Wyman, Farouc Jaffer

November 01, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone

November 01, 2017

Presentation TCT 2017

Complications During and After PFO Closure, Case #1: Pericardial Effusion

Presenter: John F. Rhodes, Robert J. Sommer, Igor F. Palacios

November 01, 2017

Presentation TCT 2017

30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Presenter: Mayra Guerrero

November 01, 2017

Presentation TCT 2017

Point A Multi-Device Lesion-Specific Approach is Preferred!

Presenter: Michael J. Reardon

November 01, 2017

Presentation TCT 2017

Current Results of Transcatheter PV Therapy: Melody and Sapien

Presenter: Elchanan Bruckheimer, Doff B. McElhinney, Thomas K. Jones

November 01, 2017

Presentation TCT 2017

Case #10 (With Discussion): Stent Underexpansion and Restenosis Secondary to Implantation in a Severely Calcified Lesion

Presenter: Akiko Maehara, Jose M. de la Torre Hernandez, Margaret B. McEntegart

November 01, 2017

Presentation TCT 2017

Case #3: IVC Filter/Obstructed IVC

Presenter: John F. Rhodes, Robert J. Sommer, Anita Asgar

November 01, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Advertisement

Slides

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

My Worst Complication That Was Preventable

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Complications During and After PFO Closure, Case #1: Pericardial Effusion

30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Point A Multi-Device Lesion-Specific Approach is Preferred!

Current Results of Transcatheter PV Therapy: Melody and Sapien

Case #10 (With Discussion): Stent Underexpansion and Restenosis Secondary to Implantation in a Severely Calcified Lesion

Case #3: IVC Filter/Obstructed IVC

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content